PL394559A1 - Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania - Google Patents

Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania

Info

Publication number
PL394559A1
PL394559A1 PL394559A PL39455911A PL394559A1 PL 394559 A1 PL394559 A1 PL 394559A1 PL 394559 A PL394559 A PL 394559A PL 39455911 A PL39455911 A PL 39455911A PL 394559 A1 PL394559 A1 PL 394559A1
Authority
PL
Poland
Prior art keywords
methyl
ylopyrimidin
methylopiperazin
benzamide
pyridin
Prior art date
Application number
PL394559A
Other languages
English (en)
Inventor
Andrzej Ostrowicz
Original Assignee
Biofarm Spólka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarm Spólka Z Ograniczona Odpowiedzialnoscia filed Critical Biofarm Spólka Z Ograniczona Odpowiedzialnoscia
Priority to PL394559A priority Critical patent/PL394559A1/pl
Publication of PL394559A1 publication Critical patent/PL394559A1/pl

Links

PL394559A 2011-04-14 2011-04-14 Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania PL394559A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL394559A PL394559A1 (pl) 2011-04-14 2011-04-14 Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL394559A PL394559A1 (pl) 2011-04-14 2011-04-14 Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
PL394559A1 true PL394559A1 (pl) 2012-10-22

Family

ID=47076785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394559A PL394559A1 (pl) 2011-04-14 2011-04-14 Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania

Country Status (1)

Country Link
PL (1) PL394559A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3257499A1 (en) 2016-06-17 2017-12-20 Vipharm S.A. Process for preparation of imatinib methanesulfonate capsules

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3257499A1 (en) 2016-06-17 2017-12-20 Vipharm S.A. Process for preparation of imatinib methanesulfonate capsules

Similar Documents

Publication Publication Date Title
ZA201306072B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
SG11201401907TA (en) Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
IL229037A0 (en) A process for the preparation of radioactively labeled compounds with deuterium containing en-alkyl groups
IL232277A0 (en) A process for the preparation of nitrogen-substituted h1-pyrazole-5-carboxylate compounds and their antecedents
EP2582671A4 (en) PROCESS FOR PREPARING A SINGLE ENANTIOMER FROM 3-AMINOPIPERIDIN DIHYDROCHLORIDE
IL230594A (en) The process of making compounds 1h- pyridine-5-carbonyl chloride is converted into nitrogen
HUE038800T2 (hu) Biokatalitikus eljárás eszlikarbazepin és ennek analógjai elõállítására
IL233937A0 (en) Process for the preparation of 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic-n-methoxy-[1-methyl-2-phenylethyl]amide
EP2736905A4 (en) INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF
IL231911A0 (en) Production method for 1-(4-(4-(4,3-dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy-piperridin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used for this
SMT201700269T1 (it) Procedimento in continuo per l'alchilazione di ammine terziarie cicliche
ZA201207397B (en) Process for the preparation of dexlansoprazole
PL3434669T3 (pl) Związki pośrednie mające zastosowanie w syntezie (-)-hupercyny i sposób otrzymywania jednego z tych związków pośrednich
PL394559A1 (pl) Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania
IL260578B (en) Pharmaceutical preparations containing 3,5-di-iodo-o-[3-iodo-4-(sulfoxy)phenyl]-l-tyrosine (t3s)
IL239228A0 (en) Improved process for the preparation of n-cyano-s-[1-(pyridine-3-yl)ethyl]-s-methylsulfylamines
IL238829B (en) Process for the preparation of 4-(cyclopropylmethoxy-3,5)-n-(dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
PL392269A1 (pl) Tabletka zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania
ZA201309732B (en) Process for the preparation of dexlansoprazole
PL2561864T3 (pl) Tabletka powlekana zawierająca tianeptynę i sposób jej otrzymywania
ZA201107792B (en) Process for the preparation of highly pure duloxetine hydrochloride
IL229920A (en) Intermediate Compounds and Method for Preparing Loracidone and its Salts
PL394758A1 (pl) Fotochromowa pochodna N-[4-[(E)-fenyloazo]fenylo]sulfonylobenzamidu i sposób jej otrzymywania
PL388511A1 (pl) Sposób zabezpieczenia stałych postaci leku zawierającego 4-[(4-metylopiperazyn -1-ylo) metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid lub jego farmaceutycznie dopuszczalne formy lub ich odmiany
PL387516A1 (pl) Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję